EUVIMEDEUVIMED entdecken
Open Access · CC BY-SA 4.0

AI-Enabled Pharmacovigilance for Defence Health Surveillance: Automatic Detection of Adverse Drug Events from Patient Reviews Using BioClinical ModernBERT

Nanang Yulian, R. Djoko Andreas Navalino, Linus Yoseph Wawan Rukmono, Riduan Riduan

Journal Of Data Insights · 30.06.2026 · 4 (1) · 128-140

DOI: 10.26714/jodi.v4i1.1192 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal Of Data Insights, online erschienen am 30.06.2026. Verfasst von Nanang Yulian und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pharmacovigilance is a critical component of post-marketing drug safety, yet conventional adverse drug event (ADE) reporting systems remain constrained by substantial underreporting. In defence health systems, the timely detection of medication-related safety signals is not only a clinical concern but also a matter of force health protection, medical readiness, and operational resilience. Patient-generated health narratives from online forums, drug review platforms, and social media provide a complementary source of pharmacovigilance intelligence, but their informal, unstructured, and context-dependent nature creates significant challenges for automated analysis. This study evaluates BioClinical ModernBERT, a biomedical–clinical long-context encoder based on the ModernBERT architecture, for automatic ADE detection from patient reviews. Its performance is compared with three representative BERT-based transformer baselines: BERT-base, BioBERT, and ClinicalBERT. Experiments were conducted using the CSIRO Adverse Drug Event Corpus (CADEC), a benchmark corpus of patient-reported medication experiences from online health forums. The corpus was pre-processed through sentence segmentation, text cleaning, medical entity normalization, and sentence-level label alignment for binary ADE/non-ADE classification. All models were fine-tuned using a 70:15:15 training, validation, and test split and evaluated using accuracy, precision, recall, and F1-score. The results show that BioClinical ModernBERT achieved the highest overall performance, with an F1-score of 0.891, outperforming ClinicalBERT (0.847), BioBERT (0.832), and BERT-base (0.798). Confusion matrix analysis further indicates that BioClinical ModernBERT reduced false negative errors, particularly in long, multi-clause, and clinically implicit patient narratives. These findings suggest that combining biomedical–clinical domain adaptation with long-context representation provides a meaningful advantage for detecting ADE signals in complex patient-generated text. From a defence health perspective, such capability may support the development of AI-enabled pharmacovigilance surveillance systems that enhance medication safety, health intelligence, and readiness-oriented risk monitoring across civilian–military health ecosystems.

Zitieren

APA

Yulian, N., Navalino, R. D. A., Rukmono, L. Y. W., & Riduan, R. (2026). AI-Enabled Pharmacovigilance for Defence Health Surveillance: Automatic Detection of Adverse Drug Events from Patient Reviews Using BioClinical ModernBERT. Journal Of Data Insights, 4(1), 128-140. https://doi.org/10.26714/jodi.v4i1.1192

Vancouver

Yulian N, Navalino RDA, Rukmono LYW, Riduan R. AI-Enabled Pharmacovigilance for Defence Health Surveillance: Automatic Detection of Adverse Drug Events from Patient Reviews Using BioClinical ModernBERT. Journal Of Data Insights. 2026;4(1):128-140. doi:10.26714/jodi.v4i1.1192

BibTeX
@article{Yulian2026,
  author = {Yulian, Nanang and Navalino, R. Djoko Andreas and Rukmono, Linus Yoseph Wawan and Riduan, Riduan},
  title = {AI-Enabled Pharmacovigilance for Defence Health Surveillance: Automatic Detection of Adverse Drug Events from Patient Reviews Using BioClinical ModernBERT},
  journal = {Journal Of Data Insights},
  year = {2026},
  volume = {4},
  number = {1},
  pages = {128--140},
  doi = {10.26714/jodi.v4i1.1192}
}
Kostenlos starten →